239 related articles for article (PubMed ID: 33045225)
1. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract][Full Text] [Related]
2. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
3. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
[TBL] [Abstract][Full Text] [Related]
7. Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Saksena A; Jain A; Pack SD; Kim J; Lee I; Tyagi M; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):409-419. PubMed ID: 36461146
[TBL] [Abstract][Full Text] [Related]
8. Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation.
Trecourt A; Mauduit C; Szablewski V; Fontaine J; Balme B; Donzel M; Laurent C; Sesques P; Ghesquières H; Bachy E; Salles G; Emile JF; Chassagne-Clément C; Genestier L; Copie-Bergman C; Traverse-Glehen A
Am J Surg Pathol; 2022 Jan; 46(1):58-70. PubMed ID: 34265801
[TBL] [Abstract][Full Text] [Related]
9. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.
Koning MT; Quinten E; Zoutman WH; Kiełbasa SM; Mei H; van Bergen CAM; Jansen P; Vergroesen RD; Willemze R; Vermeer MH; Tensen CP; Veelken H
J Invest Dermatol; 2019 Oct; 139(10):2195-2203. PubMed ID: 31042459
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.
Pham-Ledard A; Cowppli-Bony A; Doussau A; Prochazkova-Carlotti M; Laharanne E; Jouary T; Belaud-Rotureau MA; Vergier B; Merlio JP; Beylot-Barry M
Am J Clin Pathol; 2015 Mar; 143(3):362-73. PubMed ID: 25696794
[TBL] [Abstract][Full Text] [Related]
11. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.
Laurent C; Adélaïde J; Guille A; Tesson B; Gat E; Evrard S; Escudié F; Syrykh C; Canioni D; Fabiani B; Meignin V; Chassagne-Clement C; Dartigues P; Traverse-Glehen A; Parrens M; Huet S; Copie-Bergman C; Salles G; Birnbaum D; Brousset P; Morschhauser F; Xerri L;
Am J Surg Pathol; 2021 Oct; 45(10):1324-1336. PubMed ID: 34334687
[TBL] [Abstract][Full Text] [Related]
12. Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.
Chaudhary S; Brown N; Song JY; Yang L; Skrabek P; Nasr MR; Wong JT; Bedell V; Murata-Collins J; Kochan L; Li J; Zhang W; Chan WC; Weisenburger DD; Perry AM
Hum Pathol; 2021 Aug; 114():19-27. PubMed ID: 33964277
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas.
Kim BK; Surti U; Pandya A; Cohen J; Rabkin MS; Swerdlow SH
Am J Surg Pathol; 2005 Jan; 29(1):69-82. PubMed ID: 15613857
[TBL] [Abstract][Full Text] [Related]
14. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
16. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.
Brune MM; Vela V; Bratic Hench I; Dertinger S; Borgmann V; Dirnhofer S; Tzankov A
Virchows Arch; 2022 Sep; 481(3):489-497. PubMed ID: 35661922
[TBL] [Abstract][Full Text] [Related]
17. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation.
Gibson SE; Liu YC; Yatsenko SA; Barasch NJ; Swerdlow SH
Mod Pathol; 2022 Jan; 35(1):60-68. PubMed ID: 34601504
[TBL] [Abstract][Full Text] [Related]
20. Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
Carreras J; Ikoma H; Kikuti YY; Miyaoka M; Hiraiwa S; Tomita S; Kondo Y; Ito A; Nagase S; Miura H; Kawada H; Roncador G; Campo E; Hamoudi R; Nakamura N
Virchows Arch; 2024 Apr; 484(4):657-676. PubMed ID: 38462571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
